,genes,pathway,count
0,APOE,acylglycerol metabolic process (GO:0006639),34
1,APOE,positive regulation of neuron differentiation (GO:0045666),34
2,APOE,second-messenger-mediated signaling (GO:0019932),34
3,APOE,positive regulation of neuron projection development (GO:0010976),34
4,APOE,regulation of extent of cell growth (GO:0061387),34
5,APOE,regulation of cholesterol metabolic process (GO:0090181),34
6,APOE,regulation of dendritic spine development (GO:0060998),34
7,APOE,phospholipid transport (GO:0015914),34
8,APOE,negative regulation of amyloid-beta formation (GO:1902430),34
9,APOE,lipid transport (GO:0006869),34
10,APOE,amyloid precursor protein metabolic process (GO:0042982),34
11,APOE,negative regulation of inflammatory response (GO:0050728),34
12,APOE,positive regulation of monooxygenase activity (GO:0032770),34
13,APOE,regulation of blood vessel endothelial cell migration (GO:0043535),34
14,APOE,cyclic-nucleotide-mediated signaling (GO:0019935),34
15,APOE,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),34
16,APOE,positive regulation of biosynthetic process (GO:0009891),34
17,APOE,cholesterol homeostasis (GO:0042632),34
18,APOE,positive regulation of nitric-oxide synthase activity (GO:0051000),34
19,APOE,long-chain fatty acid transport (GO:0015909),34
20,APOE,regulation of membrane protein ectodomain proteolysis (GO:0051043),34
21,APOE,regulation of neuronal synaptic plasticity (GO:0048168),34
22,APOE,positive regulation of endocytosis (GO:0045807),34
23,APOE,positive regulation of transport (GO:0051050),34
24,APOE,positive regulation of cell projection organization (GO:0031346),34
25,APOE,sterol metabolic process (GO:0016125),34
26,APOE,regulation of cholesterol biosynthetic process (GO:0045540),34
27,APOE,triglyceride metabolic process (GO:0006641),34
28,APOE,neuron projection regeneration (GO:0031102),34
29,APOE,positive regulation of lipid biosynthetic process (GO:0046889),34
30,APOE,long-term memory (GO:0007616),34
31,APOE,sterol homeostasis (GO:0055092),34
32,APOE,regulation of axonogenesis (GO:0050770),34
33,APOE,negative regulation of cell projection organization (GO:0031345),34
34,TGFB1,positive regulation of transcription regulatory region DNA binding (GO:2000679),29
35,TGFB1,positive regulation of biomineral tissue development (GO:0070169),29
36,TGFB1,regulation of peptidyl-threonine phosphorylation (GO:0010799),29
37,TGFB1,response to cholesterol (GO:0070723),29
38,TGFB1,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),29
39,TGFB1,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),29
40,TGFB1,negative regulation of gene silencing by miRNA (GO:0060965),29
41,TGFB1,ATP biosynthetic process (GO:0006754),29
42,TGFB1,protein export from nucleus (GO:0006611),29
43,TGFB1,positive regulation of extracellular matrix organization (GO:1903055),29
44,TGFB1,positive regulation of peptide secretion (GO:0002793),29
45,TGFB1,negative regulation of protein localization to membrane (GO:1905476),29
46,TGFB1,positive regulation of blood vessel endothelial cell migration (GO:0043536),29
47,TGFB1,chordate embryonic development (GO:0043009),29
48,TGFB1,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),29
49,TGFB1,negative regulation of cell-cell adhesion (GO:0022408),29
50,TGFB1,pathway-restricted SMAD protein phosphorylation (GO:0060389),29
51,TGFB1,regulation of protein import into nucleus (GO:0042306),29
52,TGFB1,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),29
53,TGFB1,regulation of blood vessel endothelial cell migration (GO:0043535),29
54,TGFB1,regulation of skeletal muscle tissue development (GO:0048641),29
55,TGFB1,ventricular cardiac muscle tissue morphogenesis (GO:0055010),29
56,TGFB1,positive regulation of bone mineralization (GO:0030501),29
57,TGFB1,response to estradiol (GO:0032355),29
58,TGFB1,purine ribonucleotide biosynthetic process (GO:0009152),29
59,TGFB1,negative regulation of RNA metabolic process (GO:0051253),29
60,TGFB1,regulation of protein localization to plasma membrane (GO:1903076),29
61,TGFB1,negative regulation of cell growth (GO:0030308),29
62,TGFB1,negative regulation of protein localization to cell periphery (GO:1904376),29
63,DMTN,negative regulation of adherens junction organization (GO:1903392),22
64,DLG4,positive regulation of synaptic transmission (GO:0050806),22
65,DMTN,regulation of filopodium assembly (GO:0051489),22
66,DMTN,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),22
67,DMTN,cellular response to cAMP (GO:0071320),22
68,DMTN,calcium-mediated signaling using intracellular calcium source (GO:0035584),22
69,DMTN,negative regulation of intracellular protein transport (GO:0090317),22
70,DMTN,myeloid cell development (GO:0061515),22
71,DMTN,regulation of cytoskeleton organization (GO:0051493),22
72,DLG4,regulation of protein tyrosine kinase activity (GO:0061097),22
73,DMTN,negative regulation of cell-matrix adhesion (GO:0001953),22
74,DLG4,regulation of long-term neuronal synaptic plasticity (GO:0048169),22
75,DMTN,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),22
76,DLG4,receptor clustering (GO:0043113),22
77,DLG4,positive regulation of excitatory postsynaptic potential (GO:2000463),22
78,DMTN,regulation of actin cytoskeleton organization (GO:0032956),22
79,DLG4,protein localization to synapse (GO:0035418),22
80,DLG4,dendritic spine morphogenesis (GO:0060997),22
81,DLG4,negative regulation of receptor internalization (GO:0002091),22
82,DLG4,regulation of neurotransmitter receptor activity (GO:0099601),22
83,DLG4,regulation of neuronal synaptic plasticity (GO:0048168),22
84,DLG4,regulation of NMDA receptor activity (GO:2000310),22
85,DLG4,regulation of cation channel activity (GO:2001257),22
86,DLG4,regulation of glutamate receptor signaling pathway (GO:1900449),22
87,DLG4,receptor localization to synapse (GO:0097120),22
88,DLG4,dendritic spine organization (GO:0097061),22
89,DLG4,modulation of chemical synaptic transmission (GO:0050804),22
90,DLG4,neurotransmitter receptor diffusion trapping (GO:0099628),22
91,DLG4,dendrite morphogenesis (GO:0048813),22
92,DLG4,negative regulation of receptor-mediated endocytosis (GO:0048261),22
93,DLG4,positive regulation of signaling (GO:0023056),22
94,DMTN,regulation of actin filament-based process (GO:0032970),22
95,DMTN,response to cAMP (GO:0051591),22
96,PTK2B,negative regulation of ion transport (GO:0043271),22
97,DMTN,regulation of wound healing (GO:0061041),22
98,PTK2B,regulation of cation channel activity (GO:2001257),22
99,PTK2B,vascular endothelial growth factor receptor signaling pathway (GO:0048010),22
100,PTK2B,positive regulation of excitatory postsynaptic potential (GO:2000463),22
101,PTK2B,regulation of actin filament polymerization (GO:0030833),22
102,PTK2B,regulation of actin cytoskeleton organization (GO:0032956),22
103,PTK2B,positive regulation of neuron differentiation (GO:0045666),22
104,PTK2B,negative regulation of biomineral tissue development (GO:0070168),22
105,PTK2B,positive regulation of cell projection organization (GO:0031346),22
106,PTK2B,regulation of glutamate receptor signaling pathway (GO:1900449),22
107,PTK2B,cellular response to retinoic acid (GO:0071300),22
108,PTK2B,regulation of neurotransmitter receptor activity (GO:0099601),22
109,PTK2B,positive regulation of cytoskeleton organization (GO:0051495),22
110,PTK2B,regulation of establishment or maintenance of cell polarity (GO:0032878),22
111,PTK2B,long-term synaptic potentiation (GO:0060291),22
112,PTK2B,positive regulation of neuron projection development (GO:0010976),22
113,PTK2B,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",22
114,PTK2B,regulation of calcium ion transport into cytosol (GO:0010522),22
115,PTK2B,positive regulation of synaptic transmission (GO:0050806),22
116,PTK2B,regulation of establishment of cell polarity (GO:2000114),22
117,PTK2B,regulation of calcium ion transmembrane transport (GO:1903169),22
118,DLG4,postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),22
119,DMTN,negative regulation of cell junction assembly (GO:1901889),22
120,DMTN,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),22
121,DMTN,regulation of peptidyl-threonine phosphorylation (GO:0010799),22
122,DMTN,regulation of lamellipodium organization (GO:1902743),22
123,DMTN,calcium-mediated signaling (GO:0019722),22
124,DMTN,negative regulation of protein localization to membrane (GO:1905476),22
125,DMTN,lamellipodium organization (GO:0097581),22
126,DMTN,negative regulation of focal adhesion assembly (GO:0051895),22
127,DLG4,positive regulation of protein tyrosine kinase activity (GO:0061098),22
128,PTK2B,regulation of NMDA receptor activity (GO:2000310),22
129,CAV3,triglyceride metabolic process (GO:0006641),17
130,CAV3,acylglycerol metabolic process (GO:0006639),17
131,CAV3,regulation of microtubule polymerization (GO:0031113),17
132,CAV3,organic substance transport (GO:0071702),17
133,CAV3,regulation of cardiac muscle cell contraction (GO:0086004),17
134,CAV3,muscle contraction (GO:0006936),17
135,CAV3,negative regulation of ion transport (GO:0043271),17
136,CAV3,sterol homeostasis (GO:0055092),17
137,CAV3,regulation of calcium ion transmembrane transport (GO:1903169),17
138,CAV3,lipid transport (GO:0006869),17
139,CAV3,muscle cell development (GO:0055001),17
140,CAV3,regulation of heart contraction (GO:0008016),17
141,CAV3,regulation of calcium ion transmembrane transporter activity (GO:1901019),17
142,CAV3,plasma membrane organization (GO:0007009),17
143,CAV3,regulation of membrane depolarization (GO:0003254),17
144,CAV3,cholesterol homeostasis (GO:0042632),17
145,CAV3,regulation of blood circulation (GO:1903522),17
146,PRNP,dendritic spine organization (GO:0097061),16
147,RPL23A,ncRNA processing (GO:0034470),16
148,RPL23A,rRNA processing (GO:0006364),16
149,RPS27,cellular macromolecule biosynthetic process (GO:0034645),16
150,RPL23A,translation (GO:0006412),16
151,RPL23A,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),16
152,PRNP,calcium-mediated signaling using intracellular calcium source (GO:0035584),16
153,RPL3,viral transcription (GO:0019083),16
154,RPL3,protein targeting to ER (GO:0045047),16
155,RPL23A,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",16
156,RPL23A,rRNA metabolic process (GO:0016072),16
157,RPL23A,ribosomal large subunit biogenesis (GO:0042273),16
158,RPL23A,viral gene expression (GO:0019080),16
159,PRNP,neuron projection maintenance (GO:1990535),16
160,RPL23A,ribosome assembly (GO:0042255),16
161,RPL23A,cellular macromolecule biosynthetic process (GO:0034645),16
162,RPL3,ribosomal large subunit assembly (GO:0000027),16
163,RPS27,ncRNA processing (GO:0034470),16
164,RPS27,ribosomal small subunit biogenesis (GO:0042274),16
165,RPL23A,ribosomal large subunit assembly (GO:0000027),16
166,RPS27,viral transcription (GO:0019083),16
167,RPS27,ribosome assembly (GO:0042255),16
168,RPS27,cotranslational protein targeting to membrane (GO:0006613),16
169,RPS27,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),16
170,RPL3,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),16
171,RPS27,rRNA processing (GO:0006364),16
172,RPS27,protein targeting to ER (GO:0045047),16
173,RPS27,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",16
174,RPS27,rRNA metabolic process (GO:0016072),16
175,RPS27,peptide biosynthetic process (GO:0043043),16
176,RPS27,ribosomal small subunit assembly (GO:0000028),16
177,RPS27,translation (GO:0006412),16
178,RPL3,rRNA processing (GO:0006364),16
179,RPS27,ribosome biogenesis (GO:0042254),16
180,PRNP,positive regulation of protein tyrosine kinase activity (GO:0061098),16
181,PRNP,negative regulation of cell projection organization (GO:0031345),16
182,RPL23A,ribosome biogenesis (GO:0042254),16
183,RPL23A,cotranslational protein targeting to membrane (GO:0006613),16
184,RPL23A,peptide biosynthetic process (GO:0043043),16
185,RPL23A,protein targeting to ER (GO:0045047),16
186,RPL23A,viral transcription (GO:0019083),16
187,RPL3,ribosomal large subunit biogenesis (GO:0042273),16
188,RPL3,rRNA metabolic process (GO:0016072),16
189,RPL3,viral gene expression (GO:0019080),16
190,RPL3,translation (GO:0006412),16
191,RPL3,ribosome biogenesis (GO:0042254),16
192,RPL3,cotranslational protein targeting to membrane (GO:0006613),16
193,RPL3,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",16
194,PRNP,response to amyloid-beta (GO:1904645),16
195,PRNP,calcium-mediated signaling (GO:0019722),16
196,PRNP,regulation of protein tyrosine kinase activity (GO:0061097),16
197,PRNP,regulation of calcium ion transmembrane transport (GO:1903169),16
198,PRNP,regulation of calcium ion transport into cytosol (GO:0010522),16
199,RPL3,peptide biosynthetic process (GO:0043043),16
200,RPL3,ncRNA processing (GO:0034470),16
201,RPL3,cellular macromolecule biosynthetic process (GO:0034645),16
202,RPL3,ribosome assembly (GO:0042255),16
203,RPS27,viral gene expression (GO:0019080),16
204,PRNP,dendritic spine maintenance (GO:0097062),16
205,PRNP,cellular response to amyloid-beta (GO:1904646),16
206,PRNP,negative regulation of amyloid-beta formation (GO:1902430),16
207,PRNP,cellular response to peptide (GO:1901653),16
208,PRNP,long-term memory (GO:0007616),16
209,PRNP,regulation of interleukin-2 production (GO:0032663),16
210,CAMK2B,peptidyl-serine modification (GO:0018209),15
211,CAMK2B,regulation of dendritic spine development (GO:0060998),15
212,CAMK2B,positive regulation of neuron projection development (GO:0010976),15
213,CAMK2B,regulation of dendrite development (GO:0050773),15
214,CAMK2B,peptidyl-serine phosphorylation (GO:0018105),15
215,CAMK2B,positive regulation of cell projection organization (GO:0031346),15
216,CAMK2B,positive regulation of neuron differentiation (GO:0045666),15
217,CAMK2B,positive regulation of nervous system development (GO:0051962),15
218,CAMK2B,regulation of synapse maturation (GO:0090128),15
219,CAMK2B,positive regulation of synapse maturation (GO:0090129),15
220,CAMK2B,peptidyl-threonine phosphorylation (GO:0018107),15
221,CAMK2B,regulation of synapse organization (GO:0050807),15
222,CAMK2B,regulation of long-term neuronal synaptic plasticity (GO:0048169),15
223,CAMK2B,peptidyl-threonine modification (GO:0018210),15
224,CAMK2B,regulation of neuronal synaptic plasticity (GO:0048168),15
225,RPL41,peptide biosynthetic process (GO:0043043),14
226,RPL41,rRNA processing (GO:0006364),14
227,AKT2,mammary gland epithelial cell differentiation (GO:0060644),14
228,AKT2,regulation of fatty acid beta-oxidation (GO:0031998),14
229,AKT2,cellular response to peptide hormone stimulus (GO:0071375),14
230,AKT2,peptidyl-serine modification (GO:0018209),14
231,AKT2,positive regulation of glucose metabolic process (GO:0010907),14
232,AKT2,positive regulation of cellular carbohydrate metabolic process (GO:0010676),14
233,AKT2,peptidyl-serine phosphorylation (GO:0018105),14
234,AKT2,positive regulation of glucose import (GO:0046326),14
235,AKT2,positive regulation of glycogen biosynthetic process (GO:0045725),14
236,RPL41,ncRNA processing (GO:0034470),14
237,RPL41,protein targeting to ER (GO:0045047),14
238,RPL41,viral transcription (GO:0019083),14
239,RPL41,cellular macromolecule biosynthetic process (GO:0034645),14
240,AKT2,positive regulation of glucose transport (GO:0010828),14
241,RPL41,cytoplasmic translation (GO:0002181),14
242,RPL41,cotranslational protein targeting to membrane (GO:0006613),14
243,RPL41,ribosome biogenesis (GO:0042254),14
244,RPL41,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),14
245,RPL41,rRNA metabolic process (GO:0016072),14
246,RPL41,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",14
247,AKT2,positive regulation of transport (GO:0051050),14
248,RPL41,translation (GO:0006412),14
249,RPL41,viral gene expression (GO:0019080),14
250,AKT2,positive regulation of glycogen metabolic process (GO:0070875),14
251,AKT2,regulation of glycogen biosynthetic process (GO:0005979),14
252,AKT2,regulation of glucose import (GO:0046324),14
253,RPS25,ncRNA processing (GO:0034470),13
254,RPL13,protein targeting to ER (GO:0045047),13
255,RPL13,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",13
256,RPL13,cellular macromolecule biosynthetic process (GO:0034645),13
257,RPL13,ncRNA processing (GO:0034470),13
258,RPS25,protein targeting to ER (GO:0045047),13
259,RPL13,rRNA metabolic process (GO:0016072),13
260,RPL13,peptide biosynthetic process (GO:0043043),13
261,RPL13,cotranslational protein targeting to membrane (GO:0006613),13
262,RPL13,ribosome biogenesis (GO:0042254),13
263,RPS25,cotranslational protein targeting to membrane (GO:0006613),13
264,RPL13,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),13
265,RPL13,rRNA processing (GO:0006364),13
266,RPL13,translation (GO:0006412),13
267,RPL13,viral gene expression (GO:0019080),13
268,RPS25,ribosome biogenesis (GO:0042254),13
269,RPS25,translation (GO:0006412),13
270,RPS25,viral gene expression (GO:0019080),13
271,RPS25,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",13
272,RPS25,rRNA metabolic process (GO:0016072),13
273,RPL13,viral transcription (GO:0019083),13
274,RPS25,peptide biosynthetic process (GO:0043043),13
275,CACNG4,positive regulation of synaptic transmission (GO:0050806),13
276,RPS25,cellular macromolecule biosynthetic process (GO:0034645),13
277,CACNG4,neurotransmitter receptor transport (GO:0099637),13
278,CACNG4,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",13
279,CACNG4,regulation of neurotransmitter receptor activity (GO:0099601),13
280,CACNG4,receptor localization to synapse (GO:0097120),13
281,CACNG4,regulation of glutamate receptor signaling pathway (GO:1900449),13
282,CACNG4,"neurotransmitter receptor transport, postsynaptic endosome to lysosome (GO:0098943)",13
283,CACNG4,neurotransmitter receptor internalization (GO:0099590),13
284,RPS25,viral transcription (GO:0019083),13
285,RPS25,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),13
286,CACNG4,establishment of protein localization to vacuole (GO:0072666),13
287,CACNG4,neurotransmitter receptor diffusion trapping (GO:0099628),13
288,CACNG4,regulation of AMPA receptor activity (GO:2000311),13
289,CACNG4,regulation of cation channel activity (GO:2001257),13
290,RPS25,rRNA processing (GO:0006364),13
291,CACNG4,postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),13
292,APOD,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),11
293,APOD,negative regulation of intracellular protein transport (GO:0090317),11
294,APOD,negative regulation of focal adhesion assembly (GO:0051895),11
295,APOD,negative regulation of adherens junction organization (GO:1903392),11
296,APOD,negative regulation of cell junction assembly (GO:1901889),11
297,APOD,axon regeneration (GO:0031103),11
298,APOD,negative regulation of inflammatory response (GO:0050728),11
299,APOD,negative regulation of protein import into nucleus (GO:0042308),11
300,APOD,response to axon injury (GO:0048678),11
301,APOD,negative regulation of cell-matrix adhesion (GO:0001953),11
302,APOD,regulation of protein import into nucleus (GO:0042306),11
303,LRP4,protein heterotetramerization (GO:0051290),10
304,PKD1,chordate embryonic development (GO:0043009),10
305,PKD1,peptidyl-serine modification (GO:0018209),10
306,PKD1,protein export from nucleus (GO:0006611),10
307,PKD1,cytoplasmic sequestering of protein (GO:0051220),10
308,PKD1,lung development (GO:0030324),10
309,LRP4,dendrite morphogenesis (GO:0048813),10
310,PKD1,skeletal system development (GO:0001501),10
311,LRP4,receptor clustering (GO:0043113),10
312,LRP4,cell morphogenesis involved in neuron differentiation (GO:0048667),10
313,PKD1,cytoplasmic sequestering of transcription factor (GO:0042994),10
314,PKD1,in utero embryonic development (GO:0001701),10
315,LRP4,regulation of axonogenesis (GO:0050770),10
316,PKD1,detection of mechanical stimulus (GO:0050982),10
317,LRP4,neuromuscular junction development (GO:0007528),10
318,LRP4,presynaptic membrane assembly (GO:0097105),10
319,LRP4,presynaptic membrane organization (GO:0097090),10
320,PKD1,peptidyl-serine phosphorylation (GO:0018105),10
321,LRP4,regulation of ossification (GO:0030278),10
322,LRP4,presynapse assembly (GO:0099054),10
323,SYN1,regulation of synaptic vesicle transport (GO:1902803),8
324,SYN1,regulation of neurotransmitter transport (GO:0051588),8
325,CSNK1E,regulation of cellular localization (GO:0060341),8
326,STK11,negative regulation of cell growth (GO:0030308),8
327,SYN1,regulation of neurotransmitter secretion (GO:0046928),8
328,BAIAP2,cell morphogenesis involved in neuron differentiation (GO:0048667),8
329,MRPL34,cellular macromolecule biosynthetic process (GO:0034645),8
330,MRPL34,mitochondrial translational termination (GO:0070126),8
331,MRPL34,translational elongation (GO:0006414),8
332,MRPL34,mitochondrial translation (GO:0032543),8
333,MRPL34,translation (GO:0006412),8
334,MRPL34,mitochondrial translational elongation (GO:0070125),8
335,MRPL34,translational termination (GO:0006415),8
336,STK11,peptidyl-threonine modification (GO:0018210),8
337,STK11,positive regulation of autophagy (GO:0010508),8
338,NDUFA12,ATP synthesis coupled electron transport (GO:0042773),8
339,NDUFA12,NADH dehydrogenase complex assembly (GO:0010257),8
340,STK11,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),8
341,NDUFA12,respiratory electron transport chain (GO:0022904),8
342,NDUFA12,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",8
343,NDUFA12,mitochondrial respiratory chain complex assembly (GO:0033108),8
344,NDUFA12,mitochondrial ATP synthesis coupled electron transport (GO:0042775),8
345,NDUFA12,mitochondrial respiratory chain complex I biogenesis (GO:0097031),8
346,STK11,peptidyl-serine modification (GO:0018209),8
347,SYN1,regulation of calcium ion-dependent exocytosis (GO:0017158),8
348,SYN1,regulation of synaptic vesicle cycle (GO:0098693),8
349,STK11,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),8
350,CSNK1E,rRNA metabolic process (GO:0016072),8
351,MRPL34,peptide biosynthetic process (GO:0043043),8
352,MAPK8IP2,regulation of NMDA receptor activity (GO:2000310),8
353,BAIAP2,regulation of actin filament polymerization (GO:0030833),8
354,BAIAP2,vascular endothelial growth factor receptor signaling pathway (GO:0048010),8
355,STK11,peptidyl-threonine phosphorylation (GO:0018107),8
356,STK11,peptidyl-serine phosphorylation (GO:0018105),8
357,SYN1,regulation of cellular localization (GO:0060341),8
358,SYN1,modulation of chemical synaptic transmission (GO:0050804),8
359,CSNK1E,regulation of non-canonical Wnt signaling pathway (GO:2000050),8
360,CSNK1E,rRNA processing (GO:0006364),8
361,MAPK8IP2,regulation of neurotransmitter receptor activity (GO:0099601),8
362,CSNK1E,peptidyl-serine modification (GO:0018209),8
363,CSNK1E,ncRNA processing (GO:0034470),8
364,CSNK1E,ribosome biogenesis (GO:0042254),8
365,CSNK1E,peptidyl-serine phosphorylation (GO:0018105),8
366,BAIAP2,regulation of actin cytoskeleton organization (GO:0032956),8
367,MAPK8IP2,modulation of chemical synaptic transmission (GO:0050804),8
368,MAPK8IP2,regulation of cation channel activity (GO:2001257),8
369,MAPK8IP2,regulation of glutamate receptor signaling pathway (GO:1900449),8
370,BAIAP2,regulation of actin filament-based process (GO:0032970),8
371,MAPK8IP2,cell morphogenesis involved in neuron differentiation (GO:0048667),8
372,MAPK8IP2,dendrite morphogenesis (GO:0048813),8
373,NDUFA12,mitochondrial respiratory chain complex I assembly (GO:0032981),8
374,MAPK8IP2,regulation of AMPA receptor activity (GO:2000311),8
375,SYN1,regulation of secretion by cell (GO:1903530),8
376,BAIAP2,regulation of cytoskeleton organization (GO:0051493),8
377,BAIAP2,positive regulation of cytoskeleton organization (GO:0051495),8
378,BAIAP2,axon development (GO:0061564),8
379,AGRN,acetylcholine receptor signaling pathway (GO:0095500),7
380,AGRN,positive regulation of developmental growth (GO:0048639),7
381,AGRN,receptor clustering (GO:0043113),7
382,AGRN,neuronal ion channel clustering (GO:0045161),7
383,AGRN,regulation of filopodium assembly (GO:0051489),7
384,AGRN,aminoglycan metabolic process (GO:0006022),7
385,WDR12,maturation of LSU-rRNA (GO:0000470),7
386,WDR12,ribosome biogenesis (GO:0042254),7
387,WDR12,maturation of 5.8S rRNA (GO:0000460),7
388,AGRN,positive regulation of synapse assembly (GO:0051965),7
389,RTN4R,negative regulation of axon regeneration (GO:0048681),7
390,PALM,regulation of adenylate cyclase activity (GO:0045761),7
391,RIMS4,regulation of synaptic vesicle cycle (GO:0098693),7
392,RTN4R,regulation of axonogenesis (GO:0050770),7
393,RTN4R,negative regulation of cell projection organization (GO:0031345),7
394,RTN4R,negative regulation of neuron projection regeneration (GO:0070571),7
395,RTN4R,negative regulation of cell growth (GO:0030308),7
396,PALM,negative regulation of lyase activity (GO:0051350),7
397,WDR12,ncRNA processing (GO:0034470),7
398,RTN4R,regulation of axon regeneration (GO:0048679),7
399,WDR12,rRNA processing (GO:0006364),7
400,WDR12,rRNA metabolic process (GO:0016072),7
401,RIMS4,positive regulation of signaling (GO:0023056),7
402,RIMS4,regulation of calcium ion-dependent exocytosis (GO:0017158),7
403,RIMS4,regulation of synaptic vesicle transport (GO:1902803),7
404,RIMS4,regulation of neurotransmitter secretion (GO:0046928),7
405,WDR12,ribosomal large subunit biogenesis (GO:0042273),7
406,RIMS4,positive regulation of synaptic transmission (GO:0050806),7
407,PALM,negative regulation of cAMP biosynthetic process (GO:0030818),7
408,PALM,negative regulation of cyclase activity (GO:0031280),7
409,RIMS4,modulation of chemical synaptic transmission (GO:0050804),7
410,PALM,regulation of filopodium assembly (GO:0051489),7
411,RTN4R,negative regulation of response to wounding (GO:1903035),7
412,PALM,negative regulation of adenylate cyclase activity (GO:0007194),7
413,PALM,negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),7
414,SDCBP,negative regulation of receptor internalization (GO:0002091),6
415,GRM3,negative regulation of lyase activity (GO:0051350),6
416,ADGRL1,positive regulation of synapse maturation (GO:0090129),6
417,GNAI2,regulation of adenylate cyclase activity (GO:0045761),6
418,GNAI2,negative regulation of adenylate cyclase activity (GO:0007194),6
419,ADGRL1,positive regulation of nervous system development (GO:0051962),6
420,GRM3,negative regulation of adenylate cyclase activity (GO:0007194),6
421,GRM3,negative regulation of cyclase activity (GO:0031280),6
422,ADGRL1,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),6
423,GRM3,regulation of adenylate cyclase activity (GO:0045761),6
424,GRM3,modulation of chemical synaptic transmission (GO:0050804),6
425,GRM3,negative regulation of cAMP biosynthetic process (GO:0030818),6
426,ADGRL1,calcium-mediated signaling (GO:0019722),6
427,SDCBP,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),6
428,SDCBP,negative regulation of receptor-mediated endocytosis (GO:0048261),6
429,GNAI2,negative regulation of lyase activity (GO:0051350),6
430,GNAI2,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),6
431,GNAI2,negative regulation of cAMP biosynthetic process (GO:0030818),6
432,ADGRL1,calcium-mediated signaling using intracellular calcium source (GO:0035584),6
433,ADGRL1,regulation of synapse maturation (GO:0090128),6
434,DDX5,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),6
435,SDCBP,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),6
436,IL7,regulation of T cell differentiation (GO:0045580),6
437,PER1,regulation of cytokine production (GO:0001817),6
438,PER1,negative regulation of JNK cascade (GO:0046329),6
439,PER1,histone H3 deacetylation (GO:0070932),6
440,PER1,histone deacetylation (GO:0016575),6
441,PER1,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),6
442,PER1,regulation of glucocorticoid receptor signaling pathway (GO:2000322),6
443,PYGL,cellular glucan metabolic process (GO:0006073),6
444,IL7,positive regulation of B cell proliferation (GO:0030890),6
445,IL7,positive regulation of cytokine-mediated signaling pathway (GO:0001961),6
446,IL7,interleukin-7-mediated signaling pathway (GO:0038111),6
447,IL7,cellular response to interleukin-7 (GO:0098761),6
448,PYGL,glucan catabolic process (GO:0009251),6
449,SDCBP,"substrate-dependent cell migration, cell extension (GO:0006930)",6
450,PYGL,glycogen metabolic process (GO:0005977),6
451,PYGL,energy reserve metabolic process (GO:0006112),6
452,PYGL,cellular polysaccharide catabolic process (GO:0044247),6
453,PYGL,glycogen catabolic process (GO:0005980),6
454,DDX5,regulation of skeletal muscle tissue development (GO:0048641),6
455,DDX5,regulation of ossification (GO:0030278),6
456,DDX5,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",6
457,DDX5,mRNA catabolic process (GO:0006402),6
458,DDX5,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),6
459,IL7,regulation of B cell proliferation (GO:0030888),6
460,SDCBP,positive regulation of phosphate metabolic process (GO:0045937),6
461,GNAI2,negative regulation of cyclase activity (GO:0031280),6
462,SRCIN1,negative regulation of protein tyrosine kinase activity (GO:0061099),5
463,GNAS,homotypic cell-cell adhesion (GO:0034109),5
464,SLIT1,motor neuron axon guidance (GO:0008045),5
465,SLIT1,axon extension (GO:0048675),5
466,SLIT1,regulation of synapse assembly (GO:0051963),5
467,SLIT1,cell morphogenesis involved in neuron differentiation (GO:0048667),5
468,DAPK3,regulation of actin cytoskeleton organization (GO:0032956),5
469,SRCIN1,positive regulation of protein tyrosine kinase activity (GO:0061098),5
470,GNAS,bone development (GO:0060348),5
471,GNAS,platelet aggregation (GO:0070527),5
472,GNAS,skeletal system development (GO:0001501),5
473,GNAS,dopamine receptor signaling pathway (GO:0007212),5
474,GBE1,cellular glucan metabolic process (GO:0006073),5
475,GBE1,glycogen biosynthetic process (GO:0005978),5
476,GBE1,glucan biosynthetic process (GO:0009250),5
477,GBE1,energy reserve metabolic process (GO:0006112),5
478,GBE1,glycogen metabolic process (GO:0005977),5
479,DAPK3,peptidyl-serine modification (GO:0018209),5
480,DAPK3,peptidyl-threonine phosphorylation (GO:0018107),5
481,DAPK3,peptidyl-threonine modification (GO:0018210),5
482,SLIT1,axon development (GO:0061564),5
483,SRCIN1,regulation of dendritic spine development (GO:0060998),5
484,SYT7,regulation of calcium ion-dependent exocytosis (GO:0017158),5
485,SYT7,synaptic vesicle recycling (GO:0036465),5
486,SRCIN1,regulation of protein tyrosine kinase activity (GO:0061097),5
487,SYT7,synaptic vesicle cycle (GO:0099504),5
488,SYT7,calcium ion regulated exocytosis (GO:0017156),5
489,DAPK3,peptidyl-serine phosphorylation (GO:0018105),5
490,SRCIN1,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),5
491,SYT7,plasma membrane organization (GO:0007009),5
492,RPP38,ribosome biogenesis (GO:0042254),4
493,ARPP19,positive regulation of glucose transport (GO:0010828),4
494,ARPP19,positive regulation of glucose metabolic process (GO:0010907),4
495,TSHR,cellular response to peptide hormone stimulus (GO:0071375),4
496,TSHR,regulation of adenylate cyclase activity (GO:0045761),4
497,TSHR,activation of adenylate cyclase activity (GO:0007190),4
498,TUBB4A,negative regulation of protein polymerization (GO:0032272),4
499,TUBB4A,regulation of microtubule polymerization (GO:0031113),4
500,ARPP19,regulation of glucose import (GO:0046324),4
501,ARPP19,positive regulation of glucose import (GO:0046326),4
502,CFTR,bicarbonate transport (GO:0015701),4
503,CFTR,positive regulation of insulin secretion (GO:0032024),4
504,RPP38,rRNA metabolic process (GO:0016072),4
505,RPP38,rRNA processing (GO:0006364),4
506,ATP8B1,organic hydroxy compound transport (GO:0015850),4
507,ATP8B1,phospholipid transport (GO:0015914),4
508,ATP8B1,lipid transport (GO:0006869),4
509,TUBB4A,negative regulation of microtubule polymerization (GO:0031115),4
510,TUBB4A,negative regulation of microtubule polymerization or depolymerization (GO:0031111),4
511,CFTR,response to cAMP (GO:0051591),4
512,CFTR,cellular response to cAMP (GO:0071320),4
513,ATP8B1,phospholipid translocation (GO:0045332),4
514,RPP38,ncRNA processing (GO:0034470),4
515,PPP2R1A,second-messenger-mediated signaling (GO:0019932),4
516,TSHR,positive regulation of adenylate cyclase activity (GO:0045762),4
517,RAB11A,renal water homeostasis (GO:0003091),4
518,TAF7,DNA-templated transcriptional preinitiation complex assembly (GO:0070897),4
519,TAF7,ammonium transport (GO:0015696),4
520,NRXN2,protein localization to synapse (GO:0035418),4
521,NRXN2,postsynaptic density assembly (GO:0097107),4
522,NRXN2,receptor clustering (GO:0043113),4
523,NRXN2,synapse assembly (GO:0007416),4
524,RAB11A,astral microtubule organization (GO:0030953),4
525,RAB11A,pigment granule transport (GO:0051904),4
526,TAF7,"regulation of DNA-templated transcription, initiation (GO:2000142)",4
527,RAB11A,melanosome transport (GO:0032402),4
528,PPP1R9B,second-messenger-mediated signaling (GO:0019932),4
529,PPP1R9B,calcium-mediated signaling (GO:0019722),4
530,PPP1R9B,negative regulation of cell growth (GO:0030308),4
531,PPP1R9B,cellular response to ammonium ion (GO:0071242),4
532,PPP2R1A,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",4
533,PPP2R1A,negative regulation of cell growth (GO:0030308),4
534,DDX56,rRNA processing (GO:0006364),4
535,TAF7,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),4
536,MAP2K2,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),4
537,HSPA8,cellular response to unfolded protein (GO:0034620),4
538,DDX56,ncRNA processing (GO:0034470),4
539,PPP2R1A,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),4
540,DDX56,ribosome biogenesis (GO:0042254),4
541,HSPA8,negative regulation of cellular component organization (GO:0051129),4
542,HSPA8,regulation of protein transport (GO:0051223),4
543,MAP2K2,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),4
544,DDX56,rRNA metabolic process (GO:0016072),4
545,HSPA8,cellular response to topologically incorrect protein (GO:0035967),4
546,MAP2K2,ERK1 and ERK2 cascade (GO:0070371),4
547,MAP2K2,peptidyl-serine phosphorylation (GO:0018105),4
548,SLC6A8,amino acid transport (GO:0006865),3
549,SMOC1,eye development (GO:0001654),3
550,SEMA3B,semaphorin-plexin signaling pathway (GO:0071526),3
551,SEMA3B,neural crest cell development (GO:0014032),3
552,SEMA3B,regulation of axon extension involved in axon guidance (GO:0048841),3
553,SMOC1,sensory organ development (GO:0007423),3
554,SMOC1,regulation of ossification (GO:0030278),3
555,SLC6A8,creatine metabolic process (GO:0006600),3
556,SLC6A8,muscle contraction (GO:0006936),3
557,IL18,positive regulation of smooth muscle cell proliferation (GO:0048661),3
558,GPSM2,establishment of mitotic spindle orientation (GO:0000132),3
559,COX7C,mitochondrial ATP synthesis coupled electron transport (GO:0042775),3
560,RND3,regulation of actin cytoskeleton organization (GO:0032956),3
561,FGF1,regulation of endothelial cell chemotaxis (GO:2001026),3
562,FGF1,regulation of cholesterol biosynthetic process (GO:0045540),3
563,FGF1,positive regulation of cell division (GO:0051781),3
564,EEF1D,translation (GO:0006412),3
565,EEF1D,translational elongation (GO:0006414),3
566,EEF1D,cellular macromolecule biosynthetic process (GO:0034645),3
567,DNAJB2,negative regulation of inclusion body assembly (GO:0090084),3
568,DNAJB2,negative regulation of cellular component organization (GO:0051129),3
569,DNAJB2,negative regulation of cell growth (GO:0030308),3
570,COX7C,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",3
571,COX7C,respiratory electron transport chain (GO:0022904),3
572,GPSM2,regulation of protein localization to cell cortex (GO:1904776),3
573,BCAR1,B cell receptor signaling pathway (GO:0050853),3
574,CHAC2,nonribosomal peptide biosynthetic process (GO:0019184),3
575,CHAC2,glutathione biosynthetic process (GO:0006750),3
576,CHAC2,sulfur compound catabolic process (GO:0044273),3
577,CARM1,peptidyl-arginine methylation (GO:0018216),3
578,CARM1,"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)",3
579,CARM1,histone arginine methylation (GO:0034969),3
580,BCAR1,vascular endothelial growth factor receptor signaling pathway (GO:0048010),3
581,BCAR1,neurotrophin signaling pathway (GO:0038179),3
582,CACNA1A,response to amyloid-beta (GO:1904645),3
583,CACNA1A,cellular response to peptide (GO:1901653),3
584,GPSM2,positive regulation of cytoskeleton organization (GO:0051495),3
585,GYS1,glucan biosynthetic process (GO:0009250),3
586,TF,response to iron ion (GO:0010039),3
587,GYS1,glycogen metabolic process (GO:0005977),3
588,RND3,regulation of actin filament-based process (GO:0032970),3
589,RND3,regulation of cytoskeleton organization (GO:0051493),3
590,PPA2,translation (GO:0006412),3
591,PPA2,tRNA aminoacylation for protein translation (GO:0006418),3
592,PPA2,tRNA aminoacylation (GO:0043039),3
593,PDE5A,purine ribonucleotide catabolic process (GO:0009154),3
594,PDE5A,cyclic nucleotide catabolic process (GO:0009214),3
595,PDE5A,cGMP metabolic process (GO:0046068),3
596,PDE4A,cAMP metabolic process (GO:0046058),3
597,PDE4A,purine ribonucleotide catabolic process (GO:0009154),3
598,PDE4A,cyclic nucleotide catabolic process (GO:0009214),3
599,CACNA1A,cellular response to amyloid-beta (GO:1904646),3
600,TF,positive regulation of endocytosis (GO:0045807),3
601,TF,retina homeostasis (GO:0001895),3
602,LARP1,cellular response to alcohol (GO:0097306),3
603,LARP1,TORC1 signaling (GO:0038202),3
604,LARP1,positive regulation of autophagy (GO:0010508),3
605,IL18,cholesterol homeostasis (GO:0042632),3
606,IL18,sterol homeostasis (GO:0055092),3
607,HMGN1,"regulation of DNA-templated transcription, elongation (GO:0032784)",3
608,HMGN1,transcription-coupled nucleotide-excision repair (GO:0006283),3
609,HMGN1,nucleotide-excision repair (GO:0006289),3
610,GYS1,glycogen biosynthetic process (GO:0005978),3
611,ZER1,regulation of ubiquitin-protein transferase activity (GO:0051438),2
612,VRK2,peptidyl-serine modification (GO:0018209),2
613,SUMO3,nucleotide-excision repair (GO:0006289),2
614,VRK2,peptidyl-serine phosphorylation (GO:0018105),2
615,UBTF,positive regulation of transcription from RNA polymerase I promoter (GO:0045943),2
616,UBTF,termination of RNA polymerase I transcription (GO:0006363),2
617,SUMO3,negative regulation of DNA binding (GO:0043392),2
618,ACAP3,regulation of ARF protein signal transduction (GO:0032012),2
619,MAST3,peptidyl-serine modification (GO:0018209),2
620,SLC7A5,amino acid transport (GO:0006865),2
621,LRFN4,axon development (GO:0061564),2
622,JUND,response to purine-containing compound (GO:0014074),2
623,JUND,response to cAMP (GO:0051591),2
624,HHIP,skeletal system development (GO:0001501),2
625,HHIP,skeletal system morphogenesis (GO:0048705),2
626,GRIK5,modulation of chemical synaptic transmission (GO:0050804),2
627,GNAO1,dopamine receptor signaling pathway (GO:0007212),2
628,GNAO1,muscle contraction (GO:0006936),2
629,GIT1,regulation of Ras protein signal transduction (GO:0046578),2
630,GIT1,regulation of ARF protein signal transduction (GO:0032012),2
631,FN1,endoderm formation (GO:0001706),2
632,FN1,extracellular matrix disassembly (GO:0022617),2
633,DUOX1,response to purine-containing compound (GO:0014074),2
634,DUOX1,response to cAMP (GO:0051591),2
635,DOCK5,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),2
636,DOCK5,regulation of vascular associated smooth muscle cell migration (GO:1904752),2
637,DOCK2,positive regulation of endocytosis (GO:0045807),2
638,DOCK2,positive regulation of phagocytosis (GO:0050766),2
639,DNAJB6,negative regulation of cellular component organization (GO:0051129),2
640,DNAJB6,negative regulation of inclusion body assembly (GO:0090084),2
641,CRYAB,muscle contraction (GO:0006936),2
642,CRYAB,negative regulation of transport (GO:0051051),2
643,CAPZB,regulation of lamellipodium organization (GO:1902743),2
644,CAPZB,regulation of filopodium assembly (GO:0051489),2
645,BSG,pyruvate metabolic process (GO:0006090),2
646,BSG,extracellular matrix disassembly (GO:0022617),2
647,AGAP3,regulation of Ras protein signal transduction (GO:0046578),2
648,AGAP3,regulation of ARF protein signal transduction (GO:0032012),2
649,ACTN4,vesicle transport along actin filament (GO:0030050),2
650,ACTN4,actin filament-based transport (GO:0099515),2
651,LRFN4,cell morphogenesis involved in neuron differentiation (GO:0048667),2
652,GRIK5,"synaptic transmission, glutamatergic (GO:0035249)",2
653,ZER1,regulation of transferase activity (GO:0051338),2
654,METAP1D,peptidyl-methionine modification (GO:0018206),2
655,PLP1,gliogenesis (GO:0042063),2
656,PLP1,axon development (GO:0061564),2
657,SGTA,positive regulation of ERAD pathway (GO:1904294),2
658,SGTA,negative regulation of ERAD pathway (GO:1904293),2
659,NTNG2,axon development (GO:0061564),2
660,NTNG2,cell morphogenesis involved in neuron differentiation (GO:0048667),2
661,SLC17A7,"synaptic transmission, glutamatergic (GO:0035249)",2
662,METAP1D,N-terminal protein amino acid modification (GO:0031365),2
663,SLC17A7,synaptic vesicle cycle (GO:0099504),2
664,SLC43A2,amino acid transport (GO:0006865),2
665,MAST3,peptidyl-serine phosphorylation (GO:0018105),2
666,MAPK11,vascular endothelial growth factor receptor signaling pathway (GO:0048010),2
667,MAPK11,cellular response to virus (GO:0098586),2
668,SLC43A2,neutral amino acid transport (GO:0015804),2
669,SLC7A5,neutral amino acid transport (GO:0015804),2
670,ACAP3,regulation of Ras protein signal transduction (GO:0046578),2
671,SHC2,vascular endothelial growth factor receptor signaling pathway (GO:0048010),1
672,CA1,bicarbonate transport (GO:0015701),1
673,WDR61,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",1
674,CYP3A5,organonitrogen compound catabolic process (GO:1901565),1
675,B3GAT2,aminoglycan metabolic process (GO:0006022),1
676,ANGPT2,regulation of blood vessel endothelial cell migration (GO:0043535),1
677,CKMT1A,creatine metabolic process (GO:0006600),1
678,CPQ,organonitrogen compound catabolic process (GO:1901565),1
679,CRKL,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1
680,CRLF3,negative regulation of cell growth (GO:0030308),1
681,RPH3A,regulation of calcium ion-dependent exocytosis (GO:0017158),1
682,RAB40C,regulation of secretion by cell (GO:1903530),1
683,CYGB,regulation of monooxygenase activity (GO:0032768),1
684,LY86,positive regulation of multi-organism process (GO:0043902),1
685,DCLRE1C,telomere capping (GO:0016233),1
686,TP53TG5,negative regulation of cell growth (GO:0030308),1
687,ITGA7,endoderm formation (GO:0001706),1
688,INF2,regulation of mitochondrion organization (GO:0010821),1
689,HDAC10,histone deacetylation (GO:0016575),1
690,ST18,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),1
691,MGST1,prostaglandin biosynthetic process (GO:0001516),1
692,MYO10,regulation of filopodium assembly (GO:0051489),1
693,MYO9B,regulation of Ras protein signal transduction (GO:0046578),1
694,GAB1,ERBB2 signaling pathway (GO:0038128),1
695,DYNLT1,establishment of mitotic spindle orientation (GO:0000132),1
696,DUSP16,protein export from nucleus (GO:0006611),1
697,PIAS4,positive regulation of protein sumoylation (GO:0033235),1
698,PKD2L2,detection of mechanical stimulus (GO:0050982),1
699,PODXL2,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),1
700,POLE2,cellular macromolecule biosynthetic process (GO:0034645),1
701,LPAR6,phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),1
702,PTGDS,prostaglandin biosynthetic process (GO:0001516),1
703,TIMP3,regulation of membrane protein ectodomain proteolysis (GO:0051043),1
704,PPFIA3,regulation of neuronal synaptic plasticity (GO:0048168),1
